Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7821282
Reference Type
Journal Article
Subtype
Review
Title
Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics
Author(s)
Pong, K
Year
2003
Is Peer Reviewed?
Yes
Journal
Expert Opinion on Biological Therapy
ISSN:
1471-2598
Publisher
TAYLOR & FRANCIS LTD
Location
ABINGDON
Volume
3
Issue
1
Page Numbers
127-139
Language
English
PMID
12718737
DOI
10.1517/14712598.3.1.127
Web of Science Id
WOS:000181266000012
URL
http://www.tandfonline.com/doi/full/10.1517/14712598.3.1.127
Exit
Abstract
Evidence of oxidative stress is apparent in both acute and chronic neurodegenerative diseases, such as stroke, Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS). Increased generation of reactive oxygen species simply overwhelm endogenous antioxidant defences, leading to subsequent oxidative damage and cell death. Tissue culture and animal models have been developed to mimic some of the biochemical changes and neuropathology found in these diseases. In doing so, it has been experimentally demonstrated that oxidative stress plays a critical role in neuronal cell death. Antioxidant enzymes, such as superoxide dismutase (SOD), catalase and glutathione peroxidase (GPx) have demonstrated therapeutic efficacy in models of neurodegeneration. However, delivery and stability issues have reduced the enthusiasm to clinically develop these proteins. Most recently, SOD mimetics, small molecules which mimic the activity of endogenous superoxide dismutase, have come to the forefront of antioxidant therapeutics. This review will examine the experimental evidence supporting the use of scavengers of superoxide anions in treating some neurodegenerative diseases, such as stroke, PD and ALS, but also the pitfalls that have met antioxidant molecules in clinical trials.
Keywords
amyotropic lateral sclerosis; antioxidants; cerebral ischaemia; free radicals; neurodegeneration; oxidative stress; Parkinson's disease; reactive oxygen species
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity